Stock Events

Stock Events

Niagen Bioscience 

$3.26
55
-$0.04-1.21% 16:12 Today

Statistics

Day High
3.34
Day Low
3.21
52W High
10.52
52W Low
2.87
Volume
179,864
Avg. Volume
711,315
Mkt Cap
257.95M
P/E Ratio
16.14
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.01
0.04
0.06
0.09
Expected EPS
0.021133
Actual EPS
N/A

Financials

13.43%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
129.42MRevenue
17.38MNet Income

Analyst Ratings

10.50Average Price Target
The highest estimate is 11.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NAGE. It's not an investment recommendation.
NVIDIA
3
NVDA
Apple
2
AAPL
Amazon
2
AMZN
Alphabet
2
GOOGL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Herbalife
HLF
Mkt Cap1.33B
Herbalife Nutrition Ltd. competes in the dietary supplements market, offering products that overlap with ChromaDex's offerings in wellness and anti-aging.
Nu Skin Enterprises
NUS
Mkt Cap230.73M
Nu Skin Enterprises, Inc. provides anti-aging and nutritional products, directly competing with ChromaDex's focus on cellular health and anti-aging solutions.
Usana Health Sciences
USNA
Mkt Cap250.36M
USANA Health Sciences, Inc. operates in the same nutritional supplement market, offering products that compete with ChromaDex's range of health supplements.
Amarin
AMRN
Mkt Cap297.62M
Amarin Corporation plc focuses on developing therapeutics to improve cardiovascular health, competing with ChromaDex's approach to health through nutritional supplements.
Hain Celestial Group
HAIN
Mkt Cap71.6M
The Hain Celestial Group, Inc. offers organic and natural products, including supplements, competing in the broader health and wellness market against ChromaDex.
Sysco
SYY
Mkt Cap40.25B
Sysco Corporation, while primarily a food distributor, has been expanding into health and wellness products, indirectly competing with ChromaDex by offering nutritional supplements in its portfolio.

About

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Show more...
CEO
Robert N. Fried
Employees
117
Country
United States
ISIN
US1710774076
WKN
000A2AG5N

Listings

XNAS
US
NAGE
F
DE
OCD1.F
STU
DE
OCD1.STU
MU
DE
OCD1.MU

0 Comments

Share your thoughts

FAQ

What is Niagen Bioscience stock price today?▼
The current price of NAGE is $3.26 USD — it has decreased by -1.21% in the past 24 hours. Watch Niagen Bioscience stock price performance more closely on the chart.
What is Niagen Bioscience stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Niagen Bioscience stocks are traded under the ticker NAGE.
Is Niagen Bioscience stock price growing?▼
NAGE stock has risen by +3.33% compared to the previous week, the month change is a +0.77% rise, over the last year Niagen Bioscience has showed a -66.67% decrease.
What is Niagen Bioscience market cap?▼
Today Niagen Bioscience has the market capitalization of 257.95M
When is the next Niagen Bioscience earnings date?▼
Niagen Bioscience is going to release the next earnings report on November 04, 2026.
What were Niagen Bioscience earnings last quarter?▼
NAGE earnings for the last quarter are 0.01 USD per share, whereas the estimation was 0.01 USD resulting in a +20% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Niagen Bioscience revenue for the last year?▼
Niagen Bioscience revenue for the last year amounts to 129.42M USD.
What is Niagen Bioscience net income for the last year?▼
NAGE net income for the last year is 17.38M USD.
How many employees does Niagen Bioscience have?▼
As of August 27, 2026, the company has 117 employees.
In which sector is Niagen Bioscience located?▼
Niagen Bioscience operates in the Health & Wellness sector.
When did Niagen Bioscience complete a stock split?▼
The last stock split for Niagen Bioscience was on December 07, 2006 with a ratio of 3.1887751:1.
Where is Niagen Bioscience headquartered?▼
Niagen Bioscience is headquartered in LOS ANGELES, United States.